A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matrices
Tóm tắt
The natural response to injury is dynamic and normally consists of complex temporal and spatial cellular changes in gene expression, which, when acting in synchrony, result in patent tissue repair and, in some instances, regeneration. However, current therapeutic regiments are static and most rely on matrices, gels and engineered skin tissue. Accordingly, there is a need to design next-generation grafting materials to enable biotherapeutic spatiotemporal targeting from clinically approved matrices. To this end, rather then focus on developing completely new grafting materials, we investigated whether phage display could be deployed onto clinically approved synthetic grafts to identify peptide motifs capable of linking pharmaceutical drugs with differential affinities and eventually, control drug delivery from matrices over both space and time. To test this hypothesis, we biopanned combinatorial peptide libraries onto different formulations of a wound-healing matrix (Integra®) and eluted the bound peptides with 1) high salt, 2) collagen and glycosaminoglycan or 3) low pH. After three to six rounds of biopanning, phage recovery and phage amplification of the bound particles, any phage that had acquired a capacity to bind the matrix was sequenced. In this first report, we identify distinct classes of matrix-binding peptides which elute differently from the screened matrix and demonstrate that they can be applied in a spatially relevant manner. We suggest that further applications of these combinatorial techniques to wound-healing matrices may offer a new way to improve the performance of clinically approved matrices so as to introduce temporal and spatial control over drug delivery.
Tài liệu tham khảo
Chan ES, Lam PK, Liew CT, Lau HC, Yen RS, King WW: A new technique to resurface wounds with composite biocompatible epidermal graft and artificial skin. J Trauma. 2001, 50: 358-362. 10.1097/00005373-200102000-00028.
Clayman MA, Clayman SM, Mozingo DW: The use of collagen-glycosaminoglycan copolymer (Integra®) for the repair of hypertrophic scars and keloids. J Burn Care Res. 2006, 27: 404-409. 10.1097/01.BCR.0000216749.72080.89.
Gravvanis AI, Tsoutsos DA, Iconomou T, Gremoutis G: The use of integra® artificial dermis to minimize donor-site morbidity after suprafascial dissection of the radial forearm flap. Microsurgery. 2007, 27: 583-587. 10.1002/micr.20406.
Mis B, Rolland E, Ronfard V: Combined use of a collagen-based dermal substitute and a fibrin-based cultured epithelium: a step toward a total skin replacement for acute wounds. Burns. 2004, 30: 713-719. 10.1016/j.burns.2004.04.007.
Schneider J, Biedermann T, Widmer D, Montano I, Meuli M, Reichmann E, Schiestl C: Matriderm versus Integra®: a comparative experimental study. Burns. 2009, 35: 51-57. 10.1016/j.burns.2008.07.018.
Chen RR, Silva EA, Yuen WW, Brock AA, Fischbach C, Lin AS, Guldberg RE, Mooney DJ: Integrated approach to designing growth factor delivery systems. FASEB J. 2007, 21: 3896-3903. 10.1096/fj.06-7873com.
Hall H: Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. Curr Pharm Des. 2007, 13: 3597-3607. 10.2174/138161207782794158.
Huang S, Fu X: Naturally derived materials-based cell and drug delivery systems in skin regeneration. J Control Release. 2009
Silva EA, Mooney DJ: Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost. 2007, 5: 590-598. 10.1111/j.1538-7836.2007.02386.x.
Wilcke I, Lohmeyer JA, Liu S, Condurache A, Kruger S, Mailander P, Machens HG: VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg. 2007, 392: 305-314. 10.1007/s00423-007-0194-1.
Zisch AH, Zeisberger SM, Ehrbar M, Djonov V, Weber CC, Ziemiecki A, Pasquale EB, Hubbell JA: Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004, 25: 3245-3257. 10.1016/j.biomaterials.2003.10.015.
Cao L, Mooney DJ: Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev. 2007, 59: 1340-1350. 10.1016/j.addr.2007.08.012.
Halstenberg S, Panitch A, Rizzi S, Hall H, Hubbell JA: Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules. 2002, 3: 710-723. 10.1021/bm015629o.
Marino P, Norreel JC, Schachner M, Rougon G, Amoureux MC: A polysialic acid mimetic peptide promotes functional recovery in a mouse model of spinal cord injury. Exp Neurol. 2009, 219: 163-174. 10.1016/j.expneurol.2009.05.009.
Markoishvili K, Tsitlanadze G, Katsarava R, Morris JG, Sulakvelidze A: A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int J Dermatol. 2002, 41: 453-458. 10.1046/j.1365-4362.2002.01451.x.
Milleret V, Simonet M, Bittermann AG, Neuenschwander P, Hall H: Cyto- and hemocompatibility of a biodegradable 3D-scaffold material designed for medical applications. J Biomed Mater Res B Appl Biomater. 2009, 91: 109-121.
Berry M, Gonzalez AM, Clarke W, Greenlees L, Barrett L, Tsang W, Seymour L, Bonadio J, Logan A, Baird A: Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci. 2001, 17: 706-716. 10.1006/mcne.2001.0975.
Gonzalez AM, Berlanga O, Leadbeater WE, Cooper-Charles L, Sims K, Logan A, Eliceiri B, Berry M, Baird A: The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodies. J Gene Med. 2009, 11: 679-688. 10.1002/jgm.1354.
Gonzalez AM, Berry M, Greenlees L, Logan A, Baird A: Matrix-mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion. J Gene Med. 2006, 8: 901-909. 10.1002/jgm.919.
Gu DL, Nguyen T, Gonzalez AM, Printz MA, Pierce GF, Sosnowski BA, Phillips ML, Chandler LA: Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther. 2004, 9: 699-711. 10.1016/j.ymthe.2004.02.018.
Peterson CY, Shaterian A, Borboa AK, Gonzalez AM, Potenza BM, Coimbra R, Eliceiri BP, Baird A: The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials. Biomaterials. 2009, 30: 6788-6793. 10.1016/j.biomaterials.2009.07.069.
Shaterian A, Borboa A, Sawada R, Costantini T, Potenza B, Coimbra R, Baird A, Eliceiri BP: Real-time analysis of the kinetics of angiogenesis and vascular permeability in an animal model of wound healing. Burns. 2009, 35: 811-817. 10.1016/j.burns.2008.12.012.
Calcutt NA, Jolivalt CG, Fernyhough P: Growth factors as therapeutics for diabetic neuropathy. Curr Drug Targets. 2008, 9: 47-59. 10.2174/138945008783431727.
Undas A, Celinska-Lowenhoff M, Stepien E, Nizankowski R, Tracz W, Szczeklik A: Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury. Thromb Haemost. 2006, 95: 1045-1047.
Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, et al: 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol. 2006, 24: 3187-3205. 10.1200/JCO.2006.06.4451.
Riedel K, Riedel F, Goessler UR, Holle G, Germann G, Sauerbier M: Current status of genetic modulation of growth factors in wound repair. Int J Mol Med. 2006, 17: 183-193.
Becker JC, Beckbauer M, Domschke W, Herbst H, Pohle T: Fibrin glue, healing of gastric mucosal injury, and expression of growth factors: results from a human in vivo study. Gastrointest Endosc. 2005, 61: 560-567. 10.1016/S0016-5107(05)00291-9.
Goldman R: Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care. 2004, 17: 24-35. 10.1097/00129334-200401000-00012.
Smith PD, Polo M, Soler PM, McClintock JS, Maggi SP, Kim YJ, Ko F, Robson CM: Efficacy of growth factors in the accelerated closure of interstices in explanted meshed human skin grafts. J Burn Care Rehabil. 2000, 21: 5-9. 10.1097/00004630-200021010-00003.
Anitua E: Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999, 14: 529-535.
Cobb JP, Brownstein BH, Watson MA, Shannon WD, Laramie JM, Qiu Y, Stormo GD, Morrissey JJ, Buchman TG, Karl IE, Hotchkiss RS: Injury in the era of genomics. Shock. 2001, 15: 165-170. 10.1097/00024382-200115030-00001.
Ganesan AK, Ho H, Bodemann B, Petersen S, Aruri J, Koshy S, Richardson Z, Le LQ, Krasieva T, Roth MG, et al: Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. PLoS Genet. 2008, 4: e1000298-10.1371/journal.pgen.1000298.
Roy S, Khanna S, Yeh PE, Rink C, Malarkey WB, Kiecolt-Glaser J, Laskowski B, Glaser R, Sen CK: Wound site neutrophil transcriptome in response to psychological stress in young men. Gene Expr. 2005, 12: 273-287. 10.3727/000000005783992025.
Tarran SL, Craft GE, Valova V, Robinson PJ, Thomas G, Markham R, Langlois NE, Vanezis P: The use of proteomics to study wound healing: a preliminary study for forensic estimation of wound age. Med Sci Law. 2007, 47: 134-140. 10.1258/rsmmsl.47.2.134.
Jansen BJ, Schalkwijk J: Transcriptomics and proteomics of human skin. Brief Funct Genomic Proteomic. 2003, 1: 326-341. 10.1093/bfgp/1.4.326.
Roy S, Khanna S, Rink C, Biswas S, Sen CK: Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics. 2008, 34: 162-184. 10.1152/physiolgenomics.00045.2008.
Roy S, Patel D, Khanna S, Gordillo GM, Biswas S, Friedman A, Sen CK: Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc Natl Acad Sci USA. 2007, 104: 14472-14477. 10.1073/pnas.0706793104.
van Ruissen F, Jansen BJ, de Jongh GJ, Zeeuwen PL, Schalkwijk J: A partial transcriptome of human epidermis. Genomics. 2002, 79: 671-678. 10.1006/geno.2002.6756.
Kueh J, Richards M, Ng SW, Chan WK, Bongso A: The search for factors in human feeders that support the derivation and propagation of human embryonic stem cells: preliminary studies using transcriptome profiling by serial analysis of gene expression. Fertil Steril. 2006, 85: 1843-1846. 10.1016/j.fertnstert.2005.11.042.
Edinger M, Hoffmann P, Contag CH, Negrin RS: Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods. 2003, 31: 172-179. 10.1016/S1046-2023(03)00127-0.
Henriquez NV, van Overveld PG, Que I, Buijs JT, Bachelier R, Kaijzel EL, Lowik CW, Clezardin P, van der Pluijm G: Advances in optical imaging and novel model systems for cancer metastasis research. Clin Exp Metastasis. 2007, 24: 699-705. 10.1007/s10585-007-9115-5.
Shah K, Weissleder R: Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx. 2005, 2: 215-225. 10.1602/neurorx.2.2.215.
Smith GP, Petrenko VA: Phage Display. Chem Rev. 1997, 97: 391-410. 10.1021/cr960065d.
Zhang N, Fang Z, Contag PR, Purchio AF, West DB: Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood. 2004, 103: 617-626. 10.1182/blood-2003-06-1820.
Nakao A, Miike S, Hatano M, Okumura K, Tokuhisa T, Ra C, Iwamoto I: Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med. 2000, 192: 151-158. 10.1084/jem.192.2.151.
Hanada T, Yoshimura A: Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002, 13: 413-421. 10.1016/S1359-6101(02)00026-6.
Smith GP: Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985, 228: 1315-1317. 10.1126/science.4001944.
Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, et al: Steps toward mapping the human vasculature by phage display. Nat Med. 2002, 8: 121-127. 10.1038/nm0202-121.
Brack SS, Silacci M, Birchler M, Neri D: Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res. 2006, 12: 3200-3208. 10.1158/1078-0432.CCR-05-2804.
Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R: Identification of receptor ligands with phage display peptide libraries. J Nucl Med. 1999, 40: 883-888.
Koivunen E, Gay DA, Ruoslahti E: Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J Biol Chem. 1993, 268: 20205-20210.
Lee SM, Lee EJ, Hong HY, Kwon MK, Kwon TH, Choi JY, Park RW, Kwon TG, Yoo ES, Yoon GS, et al: Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res. 2007, 5: 11-19. 10.1158/1541-7786.MCR-06-0069.
Muller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M: Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol. 2003, 21: 1040-1046. 10.1038/nbt856.
Pasqualini R, Koivunen E, Ruoslahti E: A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol. 1995, 130: 1189-1196. 10.1083/jcb.130.5.1189.
Pasqualini R, Ruoslahti E: Organ targeting in vivo using phage display peptide libraries. Nature. 1996, 380: 364-366. 10.1038/380364a0.
Petrenko VA, Smith GP, Mazooji MM, Quinn T: Alpha-helically constrained phage display library. Protein Eng. 2002, 15: 943-950. 10.1093/protein/15.11.943.
Pilch J, Brown DM, Komatsu M, Jarvinen TA, Yang M, Peters D, Hoffman RM, Ruoslahti E: Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci USA. 2006, 103: 2800-2804. 10.1073/pnas.0511219103.
Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E: Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest. 1998, 102: 430-437. 10.1172/JCI3008.
Trepel M, Arap W, Pasqualini R: In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol. 2002, 6: 399-404. 10.1016/S1367-5931(02)00336-8.
Koivunen E, Wang B, Ruoslahti E: Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol. 1994, 124: 373-380. 10.1083/jcb.124.3.373.
Kraft S, Diefenbach B, Mehta R, Jonczyk A, Luckenbach GA, Goodman SL: Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J Biol Chem. 1999, 274: 1979-1985. 10.1074/jbc.274.4.1979.
Cislo M, Dabrowski M, Weber-Dabrowska B, Woyton A: Bacteriophage treatment of suppurative skin infections. Arch Immunol Ther Exp (Warsz). 1987, 35: 175-183.
Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A: Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009, 18: 237-238. 240-233
Burg MA, Jensen-Pergakes K, Gonzalez AM, Ravey P, Baird A, Larocca D: Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells. Cancer Res. 2002, 62: 977-981.
Larocca D, Jensen-Pergakes K, Burg MA, Baird A: Receptor-targeted gene delivery using multivalent phagemid particles. Mol Ther. 2001, 3: 476-484. 10.1006/mthe.2001.0284.
Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A: Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J. 1999, 13: 727-734.
Kassner PD, Burg MA, Baird A, Larocca D: Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells. Biochem Biophys Res Commun. 1999, 264: 921-928. 10.1006/bbrc.1999.1603.